Kaori Sango, Ph.D.
Affiliations: | 2010 | Yeshiva University, New York, NY, United States |
Area:
ImmunologyGoogle:
"Kaori Sango"Parents
Sign in to add mentor| Harris Goldstein | grad student | 2010 | Yeshiva University | |
| (A new humanized mouse model for studying HIV infection and antiretroviral therapeutics and human hematopoietic stem cell-delivered gene therapy to generate anti-HIV cytotoxic T cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sahu GK, Sango K, Selliah N, et al. (2013) Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells. Virology. 446: 268-75 |
| Sango K, Joseph A, Patel M, et al. (2010) Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice. Aids Research and Human Retroviruses. 26: 735-46 |
| Joseph A, Sango K, Goldstein H. (2009) Novel mouse models for understanding HIV-1 pathogenesis. Methods in Molecular Biology (Clifton, N.J.). 485: 311-27 |
| Joseph A, Zheng JH, Follenzi A, et al. (2008) Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity. Journal of Virology. 82: 3078-89 |
| Frahm N, Adams S, Kiepiela P, et al. (2005) HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. Journal of Virology. 79: 10218-25 |
| Frahm N, Korber BT, Adams CM, et al. (2004) Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. Journal of Virology. 78: 2187-200 |